• Explore /
  • Poster
  • / Antitumor activity and safety of dostarlimab monotherapy in patients with mismatch repair deficient non-endometrial solid tumors: A post-hoc subgroup analysis of patients with colorectal cancer.

Antitumor activity and safety of dostarlimab monotherapy in patients with mismatch repair deficient non-endometrial solid tumors: A post-hoc subgroup analysis of patients with colorectal cancer.

Abstract Video & Slides Poster

Authors

Thierry Andre

Thierry Andre

Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France

Thierry Andre , Filippo G. De Braud , Begona Jimenez-Rodriguez , Dominique Berton , Giuseppe Curigliano , Tobias Arkenau , Antonio Antón Torres , David Paez , Susan Ellard , Cyril Abdeddaim , Eduardo Castanon Alvarez , Francine Aubin , Tao Duan , Jennifer Taylor Veneris , Eleftherios Zografos , Naureen Starling

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Other

Clinical Trial Registration Number

NCT02715284

DOI

10.1200/JCO.2022.40.4_suppl.201

Abstract #

201

Poster Bd #

K5

Abstract Disclosures

Similar Posters

First Author: Dominique Berton

First Author: Thierry Andre

First Author: Jennifer Hanlon

Poster

2020 Gastrointestinal Cancers Symposium

Safety and efficacy of anti-PD-1 antibody dostarlimab in patients (pts) with mismatch repair deficient (dMMR) GI cancers.

Safety and efficacy of anti-PD-1 antibody dostarlimab in patients (pts) with mismatch repair deficient (dMMR) GI cancers.

First Author: Thierry Andre